PhilipJonRosenthalMD
Infectious Disease • San Francisco, CAProfessor, Medicine, UCSF School of Medicine
Are you Dr. Rosenthal?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 56 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1001 Potrero Avenue
Bldg 30 4th Floor
San Francisco, CA 94110Phone+1 415-206-5438Fax+1 415-648-8425
Summary
- Dr. Philip Rosenthal, MD is an infectious disease specialist in San Francisco, California. He is currently licensed to practice medicine in California, Michigan, and New York. He is affiliated with Zuckerberg San Francisco General Hospital and Trauma Center and UCSF Medical Center.
Education & Training
University of California (San Francisco)Fellowship, Infectious Disease, 1985 - 1988
University of MichiganResidency, Internal Medicine, 1982 - 1985
New York University School of MedicineClass of 1982
Certifications & Licensure
CA State Medical License 1985 - 2026
NY State Medical License 1976 - 2021
MI State Medical License 1982 - 1988- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Relationship Between HIV and Malaria in Ugandan Children Start of enrollment: 2005 Nov 01
- Pharmacokinetics of Dihydroartemisinin-Piperaquine in the Treatment of Uncomplicated Malaria in Children in Burkina Faso Start of enrollment: 2007 Aug 01
- NAFLD Pediatric Database 2 Start of enrollment: 2010 Jan 20
- Join now to see all
Publications & Presentations
PubMed
- 7 citationsThe emergence of artemisinin partial resistance in Africa: how do we respond?Philip J Rosenthal, Victor Asua, Jeffrey A Bailey, Melissa D Conrad, Deus S Ishengoma
The Lancet. Infectious Diseases. 2024-09-01 - 8 citationsThe surge of mpox in Africa: a call for action.Jean B Nachega, Nadia A Sam-Agudu, Dimie Ogoina, Placide Mbala-Kingebeni, Francine Ntoumi
The Lancet. Global Health. 2024-07-01 - Author Correction: Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa.Philip J Rosenthal, Victor Asua, Melissa D Conrad
Nature Reviews. Microbiology. 2024-06-01
Press Mentions
2015 AST FAST DesigneesMay 21st, 2015
Grant Support
- Discovery Of Oxaboroles As New Antimalarial AgentsNational Institute Of Allergy And Infectious Diseases2012
- Discovery Of Oxaboroles As New Antimalarial AgentsNational Institute Of Allergy And Infectious Diseases2011
- Surveillance And Discovery And Mediators Of Resistance To Antimalarial Drugs AndNational Institute Of Allergy And Infectious Diseases2010–2011
- Laboratory CoreNational Institute Of Allergy And Infectious Diseases2010–2011
- Childhood Liver Disease Research And Education Network (CHILDREN) - UCSF (CC)National Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
- Resistance Of Malaria Parasites To Artemisinin-Based Combination TherapiesNational Institute Of Allergy And Infectious Diseases2009–2011
- Selection Of Drug Resistant Malaria ParasitesEunice Kennedy Shriver National Institute Of Child Health &Human Development2008–2011
- Training In Malaria Research In UgandaFogarty International Center2005–2011
- Resistance Of Malaria Parasites To Artemisinin-Based Combination TherapiesNational Institute Of Allergy And Infectious Diseases2008
- Malaria Biochemistry And Cell BiologyNational Institute Of Allergy And Infectious Diseases2004–2008
- Clinical &Molecular Studies Of Drug Resistant MalariaNational Institute Of Allergy And Infectious Diseases2003–2008
- Biliary Atresia Clinical Research ConsortiumNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2008
- Studies Of Antimalarial Drug Efficacy And Resistance In UgandaFogarty International Center2007
- Falcipain Cysteine Proteases Of Malaria ParasitesNational Institute Of Allergy And Infectious Diseases2005
- Safety, Tolerance And PK Study Of Cellcept In Pediatric Liver TransplantNational Center For Research Resources2005
- Pegylated Interferon +/- Ribavirin For Children With HCVNational Center For Research Resources2005
- A Prospective Database Of Infants With CholestasisNational Center For Research Resources2005
- Training In Malaria Research In UgandaFogarty International Center2000–2004
- Evaluation Of Falcipain As An Antimalarial Drug TargetNational Institute Of Allergy And Infectious Diseases1999–2003
- Seropositivity For H Pylori In Children W/ CancerNational Center For Research Resources2000–2002
- Parasitology And Cell Biology Of MalariaNational Institute Of Allergy And Infectious Diseases1999–2002
- Molecular Approaches To Drug Resistant MalariaNational Institute Of Allergy And Infectious Diseases1998–2000
- Recombinant Adenovirus Gene Transfer In Adults With Partial OTC DeficiencyNational Center For Research Resources1998–1999
- Protease Inhibitors To Treat Parasitic DiseasesNational Center For Research Resources1998–1999
- Malarial HemoglobinaseNational Institute Of Allergy And Infectious Diseases1994–1998
- Proteinase-Like Malarial AntigensNational Institute Of Allergy And Infectious Diseases1994–1996
- Molecular Approaches To A Malarial CysteineNational Institute Of Allergy And Infectious Diseases1988–1992
